FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Bizotic Commercial IPO and Cell Point (India) IPO.
Bizotic Commercial IPO is a SME Fixed Price Issue IPO proposed to list at BSE SME while Cell Point (India) IPO is a SME Fixed Price Issue proposed to list at NSE SME.
Bizotic Commercial IPO | Cell Point (India) IPO | |
---|---|---|
Logo | ||
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Fixed Price Issue | Fixed Price Issue |
Listing At | BSE SME | NSE SME |
Lead Managers | Interactive Financial Services Ltd | First Overseas Capital Limited |
Registrar | Bigshare Services Pvt Ltd | Bigshare Services Pvt Ltd |
Market Maker | Beeline Broking Ltd. | Nnm Securities Private Limited |
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Bizotic Commercial IPO is up to ₹42.21 Cr whereas the issue size of the Cell Point (India) IPO is up to ₹50.34 Cr. The final issue price of Bizotic Commercial IPO is ₹175.00 per share and of Cell Point (India) IPO is ₹100.00 per share.
Bizotic Commercial IPO | Cell Point (India) IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ||
Issue Price (Upper) | ||
Issue Price (Final) | ₹175.00 per share | ₹100.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 800 shares | 1200 shares |
Fresh Issue Size | 24,12,000 shares | 50,34,000 shares |
Fresh Issue Size (Amount) | up to ₹42.21 Cr | up to ₹50.34 Cr |
OFS Issue Size | ||
OFS Issue Size (Amount) | ||
Issue Size Total | 24,12,000 shares | 50,34,000 shares |
Issue Size Total (Amount) | up to ₹42.21 Cr | up to ₹50.34 Cr |
Bizotic Commercial IPO opens on Jun 12, 2023, while Cell Point (India) IPO opens on Jun 15, 2023. The closing date of Bizotic Commercial IPO and Cell Point (India) IPO is Jun 15, 2023, and Jun 20, 2023, respectively.
Bizotic Commercial IPO | Cell Point (India) IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Jun 12, 2023 | Jun 15, 2023 |
Issue Close | Jun 15, 2023 | Jun 20, 2023 |
Basis Of Allotment (Tentative) | Jun 20, 2023 | Jun 23, 2023 |
Initiation of Refunds (Tentative) | Jun 21, 2023 | Jun 26, 2023 |
Credit of Share (Tentative) | Jun 22, 2023 | Jun 27, 2023 |
Listing date (Tentative) | Jun 23, 2023 | Jun 28, 2023 |
Anchor Lockin End date 1 | Jul 20, 2023 | Jul 23, 2023 |
Anchor Lockin End date 2 | Sep 18, 2023 | Sep 21, 2023 |
Bizotic Commercial IPO P/E ratio is 36.38, as compared to Cell Point (India) IPO P/E ratio of 24.1.
Bizotic Commercial IPO | Cell Point (India) IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 100% | 100.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 73.06% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 36.38 | 24.1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹140.70 Cr. | ₹186.86 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹0.82 | ₹11.60 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 51.27%% | 10.55%% |
In the Bizotic Commercial IPO retail investors (RII) are offered 11,45,600 shares while in Cell Point (India) IPO retail investors are offered 11,45,600 shares. Qualified institutional buyers (QIB) are offered 0 shares in Bizotic Commercial IPO and 0 shares in Cell Point (India) IPO.
Bizotic Commercial IPO | Cell Point (India) IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | 1,20,800 shares | 2,52,000 shares |
QIB | 0 shares | 0 shares |
NII | 11,45,600 shares | 23,91,000 shares |
RII | 11,45,600 shares | 23,91,000 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 22,91,200 shares | 47,82,000 shares |
Bizotic Commercial IPO subscribed 1.87x in total, whereas Cell Point (India) IPO subscribed 6.03x.
Bizotic Commercial IPO | Cell Point (India) IPO | |
---|---|---|
QIB (times) | ||
NII (times) | 2.00x | 4.11x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 1.74x | 7.92x |
Employee (times) | ||
Other (times) | ||
Total (times) | 1.87x | 6.03x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|